The effects of NLY01, a novel glucagon-like Peptide-1 receptor agonist, on Cuprizone-induced demyelination and Remyelination: challenges and future perspectives
Whole cell binding assay CHO-K1 cells were seeded to 96-well plates (PerkinElmer) coated with Fibronectin (Corning) at a density of 30,000 cells per well and incubated overnight
GLP1 medications are not approved for treating ADHD, in women or in anyone else
An association between a lower risk of MACEs and the use of GLP-1 RAs persisted regardless of hypertension, advanced CKD, or insulin/metformin use
GLP-1 receptors are not only expressed in the pancreas, but also in peripheral tissues, including the central nervous system, heart, kidney, lung, and gastrointestinal tract [8,9]
Genetic polymorphisms of TFRC (Transferrin receptor 1) alter iron availability in the developing brain (Petralla et al